7th Annual Hematology and Medical Oncology Board Review: Contemporary Practice

Add to Calendar 7th Annual Hematology and Medical Oncology Board Review: Contemporary Practice 3/8/2019 8:30:00 AM 3/11/2019 12:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/HemOnc2019 Description: This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. The target audience for th... Zuckerman Research Center: 417 East 68th Street false MM/DD/YYYY

Date & Location

Friday, March 8, 2019, 8:30 AM - Monday, March 11, 2019, 12:00 PM, Zuckerman Research Center: 417 East 68th Street

Specialties

Specialties - Hematology, Medical Oncology, Oncology and Hematology

Overview

This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

The target audience for this course is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents.

Live Simulcast Available

We are pleased to offer non-MSK employees a live simulcast for the 7th Annual Hematology and Medical Oncology Board Review, available to attendees unable to attend this course in person. CME and ABIM MOC credit will still be offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge so we are happy to offer the live simulcast as an option. Register for the live simulcast.

Objectives

Learn state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers
Learn state-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers
Understand recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice

Registration

Registration Fees
Physicians (MDs, PhDs and DOs)	$1500
Residents, Fellows, Nurses and Other Healthcare Providers	$975
Industry Professionals*	$2,525

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration Discounts/Promotions

MSK CME offers a 30% discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
MSK employee registration is complimentary. However, you must complete course registration in order to attend this course.

Please note: after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 30.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Keywords: